Lilly(Eli) & Co (NYSE: LLY) has a price-to-earnings ratio that is above its average at 65.77x. The stock has a 36-month beta value of 0.40. Opinions on the stock are mixed, with 16 analysts rating it as a “buy,” 7 as “overweight,” 5 as “hold,” and 1 as “sell.”
The public float for LLY is 849.67M, and at present, short sellers hold a 0.86% of that float. On June 10, 2025, the average trading volume of LLY was 4.12M shares.
LLY) stock’s latest price update
Lilly(Eli) & Co (NYSE: LLY)’s stock price has soared by 2.62 in relation to previous closing price of 773.71. Nevertheless, the company has seen a gain of 5.75% in its stock price over the last five trading days. seekingalpha.com reported 2025-06-10 that Eli Lilly and Company (NYSE:LLY ) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 8:00 AM ET Company Participants Lucas E. Montarce – Executive VP & CFO Michael Czapar – Director of Investor Relations Conference Call Participants Unidentified Analyst Get started here.
LLY’s Market Performance
Lilly(Eli) & Co (LLY) has seen a 5.75% rise in stock performance for the week, with a 8.09% gain in the past month and a -3.65% plunge in the past quarter. The volatility ratio for the week is 0.86%, and the volatility levels for the past 30 days are at 1.89% for LLY. The simple moving average for the past 20 days is 6.72% for LLY’s stock, with a -4.22% simple moving average for the past 200 days.
Analysts’ Opinion of LLY
HSBC Securities, on the other hand, stated in their research note that they expect to see LLY reach a price target of $700, previously predicting the price at $1150. The rating they have provided for LLY stocks is “Reduce” according to the report published on April 28th, 2025.
Cantor Fitzgerald gave a rating of “Overweight” to LLY, setting the target price at $975 in the report published on April 22nd of the current year.
LLY Trading at 2.54% from the 50-Day Moving Average
After a stumble in the market that brought LLY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -18.36% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at LLY starting from Zakrowski Donald A, who sale 1,000 shares at the price of $716.41 back on May 27 ’25. After this action, Zakrowski Donald A now owns 4,840 shares of Lilly(Eli) & Co, valued at $716,410 using the latest closing price.
Yuffa Ilya, the EVP & President, LLY Int’l of Lilly(Eli) & Co, sale 1,250 shares at $749.24 during a trade that took place back on May 14 ’25, which means that Yuffa Ilya is holding 27,510 shares at $936,550 based on the most recent closing price.
Stock Fundamentals for LLY
Current profitability levels for the company are sitting at:
- 0.41 for the present operating margin
- 0.82 for the gross margin
The net margin for Lilly(Eli) & Co stands at 0.23. The total capital return value is set at 0.34. Equity return is now at value 77.73, with 14.49 for asset returns.
Based on Lilly(Eli) & Co (LLY), the company’s capital structure generated 0.71 points at debt to capital in total, while cash flow to debt ratio is standing at 0.24. The debt to equity ratio resting at 2.44. The interest coverage ratio of the stock is 23.61.
Currently, EBITDA for the company is 15.23 billion with net debt to EBITDA at 2.18. When we switch over and look at the enterprise to sales, we see a ratio of 16.15. The receivables turnover for the company is 3.5for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.
Conclusion
To sum up, Lilly(Eli) & Co (LLY) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
